Minerva Neurosciences Inc (NERV)
2.46
+0.03
(+1.23%)
USD |
NASDAQ |
Apr 26, 14:46
Minerva Neurosciences Price: 2.46 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 2.50 | 2.505 | 2.43 | 2.43 | 5770.00 |
Apr 24, 2024 | 2.53 | 2.53 | 2.47 | 2.52 | 3943.00 |
Apr 23, 2024 | 2.59 | 2.59 | 2.49 | 2.53 | 4587.00 |
Apr 22, 2024 | 2.46 | 2.58 | 2.438 | 2.55 | 10036.00 |
Apr 19, 2024 | 2.50 | 2.53 | 2.45 | 2.48 | 11385.00 |
Apr 18, 2024 | 2.49 | 2.52 | 2.390 | 2.50 | 14482.00 |
Apr 17, 2024 | 2.52 | 2.55 | 2.40 | 2.47 | 15676.00 |
Apr 16, 2024 | 2.36 | 2.80 | 2.351 | 2.50 | 68670.00 |
Apr 15, 2024 | 2.47 | 2.50 | 2.286 | 2.42 | 30363.00 |
Apr 12, 2024 | 2.51 | 2.570 | 2.45 | 2.50 | 15182.00 |
Apr 11, 2024 | 2.47 | 2.57 | 2.412 | 2.54 | 14230.00 |
Apr 10, 2024 | 2.49 | 2.53 | 2.43 | 2.47 | 7743.00 |
Apr 09, 2024 | 2.50 | 2.54 | 2.45 | 2.54 | 23474.00 |
Apr 08, 2024 | 2.51 | 2.54 | 2.485 | 2.54 | 10380.00 |
Apr 05, 2024 | 2.54 | 2.56 | 2.42 | 2.54 | 47245.00 |
Apr 04, 2024 | 2.56 | 2.59 | 2.488 | 2.53 | 9677.00 |
Apr 03, 2024 | 2.52 | 2.58 | 2.47 | 2.54 | 15363.00 |
Apr 02, 2024 | 2.53 | 2.553 | 2.48 | 2.515 | 10195.00 |
Apr 01, 2024 | 2.58 | 2.61 | 2.51 | 2.53 | 9530.00 |
Mar 28, 2024 | 2.51 | 2.587 | 2.45 | 2.58 | 28283.00 |
Mar 27, 2024 | 2.58 | 2.62 | 2.43 | 2.50 | 34730.00 |
Mar 26, 2024 | 2.63 | 2.645 | 2.52 | 2.57 | 37013.00 |
Mar 25, 2024 | 2.66 | 2.75 | 2.60 | 2.66 | 12329.00 |
Mar 22, 2024 | 2.61 | 2.68 | 2.569 | 2.67 | 29335.00 |
Mar 21, 2024 | 2.78 | 2.78 | 2.56 | 2.59 | 34416.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.43
Minimum
Dec 28 2022
117.60
Maximum
May 26 2020
21.29
Average
11.60
Median
Oct 05 2021
Price Benchmarks
Viking Therapeutics Inc | 71.78 |
Janux Therapeutics Inc | 47.40 |
ACADIA Pharmaceuticals Inc | 16.57 |
Karyopharm Therapeutics Inc | 1.075 |
Calidi Biotherapeutics Inc | 0.1611 |
Price Related Metrics
Earnings Yield | -189.4% |
Market Cap | 17.20M |